Promoter polymorphism of the EED gene is associated with the susceptibility to ulcerative colitis

Digestive Diseases and Sciences

Volumn 57, Issue 6, 2012, Pages 1537-1543

  Yu, Ji In ^a   Kang, In Hong ^a   Seo, Geom Seog ^a   Choi, Suck Chei ^a   Yun, Ki Jung ^a   Chae, Soo Cheon ^a  

^a Wonkwang University   (South Korea)

Author keywords

EED; Haplotype; IBD; Promoter assay; WAIT 1

Indexed keywords

LUCIFERASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA MICROARRAY; EED GENE; ENZYME ACTIVITY; FEMALE; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; ILEUM; LIVER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADULT; ALLELES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REFERENCE VALUES; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84864208647     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2045-3     Document Type: Article

References (32)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205. (Pubitemid 28307304)
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. (Pubitemid 34851835)
3. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol. 1999;11:648-656.
4. Travis S, Jewell DP. Ulcerative colitis: clinical presentation and diagnosis. In: Satsangi J, Sutherland LR, eds. Ciclosporin Use in Acute Ulcerative Colitis: A Long-Term Experience. New York: Churchill Livingstone; 2003:169-182.
5. Forbes A. Clinical presentation and diagnosis of Crohn's disease. In: Satsangi J, Sutherland LR, eds. Fistulating anal Crohn's Disease: Results of Combined Surgical and Infliximab Treatment. New York: Churchill Livingstone; 2003:183-189.
6. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, et al. Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN gamma, whereas, ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996;157:1261-1270. (Pubitemid 126449643)
7. Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology. 2004;126:1533-1549. (Pubitemid 38649871)
8. Cavanaugh J. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn's disease and chromosome 16. Am J Hum Genet. 2001;68:1165-1171. (Pubitemid 32424415)
9. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature. 1996;379:821-823. (Pubitemid 26067722)
10. Parkes M, Barmada MM, Satsangi J, Weeks DE, Jewell DP, et al. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn's disease. Am J Hum Genet. 2000;7:1605-1610.
11. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet. 1999;65:1647-1655. (Pubitemid 30468677)
12. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet. 2004;13:763-770. (Pubitemid 38455963)
13. Schumacher A, Lichtarge O, Schwartz S, Magnusson T. The murine Polycomb-group EED and its human orthologue: functional implications of evolutionary conservation. Genomics. 1998;54:79-88. (Pubitemid 28536196)
14. Sewalt RGAB, van der Vlag J, Gunster MJ, Hamer KM, den Blaauwen JL, et al. Characterization of interactions between the mammalian Polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian Polycomb-group protein complexes. Mol Cell Biol. 1998;18: 3586-3595. (Pubitemid 28240531)
15. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349-353. (Pubitemid 44050199)
16. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genomewide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123-1136.
17. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301-313. (Pubitemid 44313811)
18. Crowe DT, Chiu H, Fong S, Weissmann IL. Regulation of the avidity of integrin alpha4 beta7 by the beta7 cytoplasmic domain. J Biol Chem. 1994;269:14411-14418.
19. Peytavi R, Hong SS, Gay B, d'Angeac AD, Selig L, et al. H-EED, the product of the human homolog of the murine EED gene, binds to the matrix protein of HIV-1. J Biol Chem. 1999;274:1635-1645.
20. Violot S, Hong SS, Rakotobe D, Petit C, Gay B, et al. The human Polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol. 2003;77:12507-12522. (Pubitemid 37430647)
21. Witte V, Laffert B, Rosorius O, Lischka P, Blume K, et al. HIV-1 Nef mimics an integrin receptor signal that recruits the Polycomb group protein EED to the plasma membrane. Mol Cell. 2004;13: 179-190. (Pubitemid 38183265)
22. Otte AP, Kwaks THJ. Gene repression by Polycomb group protein complexes: a distinct complex for every occasion? Curr Opin Genet Dev. 2003;13:448-454. (Pubitemid 37204919)
23. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, et al. Silencing of human Polycomb target genes is associated with methylation of histone H3 Lys27. Genes Dev. 2004;18: 1592-1605. (Pubitemid 38868910)
24. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D. Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol Cell. 2004;14:183-193. (Pubitemid 38515646)
25. Cao R, Zhang Y. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EEDEZH2 complex. Mol Cell. 2004;15:57-67. (Pubitemid 38850219)
26. Rakotobe D, Violot S, Hong SS, Gouet P, Boulanger P. Mapping of immunogenic and protein-interacting regions at the surface of the seven-bladed beta-propeller domain of the HIV-1 cellular interactor EED. Virol J. 2008;27:5-32.
27. Rakotobe D, Tardy JC, André P, Hong SS, Darlix JL, et al. Human Polycomb group EED protein negatively affects HIV-1 assembly and release. Retrovirology. 2007;4:4-37.
28. Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, et al. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cell. 2010; 29:21-28.
29. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445-456. (Pubitemid 32181667)
30. Warner EE, Dieckgraefe BK. Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:140-157. (Pubitemid 34213514)
31. Park YR, Choi SC, Lee ST, Kim KS, Chae SC, et al. The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp Mol Med. 2005;37:553-558.
32. Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, et al. Interleukin 27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hapatol. 2009;24: 1692-1696.